Literature DB >> 3139834

Mechanistic positron emission tomography studies: demonstration of a deuterium isotope effect in the monoamine oxidase-catalyzed binding of [11C]L-deprenyl in living baboon brain.

J S Fowler1, A P Wolf, R R MacGregor, S L Dewey, J Logan, D J Schlyer, B Langstrom.   

Abstract

The application of positron emission tomography (PET) to the study of biochemical transformations in the living human and animal body requires the development of highly selective radiotracers whose concentrations in tissue provide a record of a discrete metabolic process. L-N-[11C-methyl]Deprenyl ([11C]L-deprenyl), a suicide inactivator of monoamine oxidase (MAO) type B, has been developed as a radiotracer for mapping MAO B in the living human and animal brain. In this investigation, [11C]L-deprenyl (1) and [11C]L-deprenyl-alpha, alpha-2H2 (2) have been compared in three different baboons by PET measurement of carbon-11 uptake and retention in the brain and the measurement of the amount of unchanged tracer in the arterial plasma over a 90-min time interval. For one baboon, N-[11C-methyl-2H3]L-deprenyl (3) was also studied. Kinetic parameters calculated using a three-compartment model revealed a deuterium isotope effect of 3.8 +/- 1.1. Comparison of the two tracers (1 and 2) in mouse brain demonstrated that deuterium substitution significantly reduced the amount of radioactivity bound to protein. HPLC and GLC analysis of the soluble radioactivity in mouse brain after injection of [11C]L-deprenyl showed the presence of [11C]methamphetamine as a major product along with unidentified labeled products. Sodium dodecyl sulfate-polyacrylamide electrophoresis with carbon-14-labeled L-deprenyl showed that a protein of molecular weight 58,000 was labeled. These results establish that MAO-catalyzed cleavage of the alpha carbon-hydrogen bond on the propargyl group is the rate limiting (or a major rate contributing) step in the retention of carbon-11 in brain and that the in vivo detection of labeled products in brain after the injection of [11C]L-deprenyl provides a record of MAO activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3139834     DOI: 10.1111/j.1471-4159.1988.tb01121.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  21 in total

Review 1.  Translational neuroimaging: positron emission tomography studies of monoamine oxidase.

Authors:  Joanna S Fowler; Jean Logan; Nora D Volkow; Gene-Jack Wang
Journal:  Mol Imaging Biol       Date:  2005 Nov-Dec       Impact factor: 3.488

2.  PET radiopharmaceuticals for probing enzymes in the brain.

Authors:  Jason P Holland; Paul Cumming; Neil Vasdev
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-04-09

3.  Synthesis and in vivo studies of a specific monoamine oxidase B inhibitor: 5-[4-(benzyloxy)phenyl]-3-(2-cyanoethyl)- 1,3,4-oxadiazol-[11C]-2(3H)-one.

Authors:  S Bernard; C Fuseau; L Schmid; R Milcent; C Crouzel
Journal:  Eur J Nucl Med       Date:  1996-02

4.  In vivo imaging of astrocytosis in Alzheimer's disease: an ¹¹C-L-deuteriodeprenyl and PIB PET study.

Authors:  Alexander Frizell Santillo; Juan Pablo Gambini; Lars Lannfelt; Bengt Långström; Luohija Ulla-Marja; Lena Kilander; Henry Engler
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-08-19       Impact factor: 9.236

Review 5.  Where have we got to with neuroreceptor mapping of the human brain?

Authors:  B Mazière; M Mazière
Journal:  Eur J Nucl Med       Date:  1990

6.  Low monoamine oxidase B in peripheral organs in smokers.

Authors:  Joanna S Fowler; Jean Logan; Gene-Jack Wang; Nora D Volkow; Frank Telang; Wei Zhu; Dinko Franceschi; Naomi Pappas; Richard Ferrieri; Colleen Shea; Victor Garza; Youwen Xu; David Schlyer; S John Gatley; Yu-Shin Ding; David Alexoff; Donald Warner; Noelwah Netusil; Pauline Carter; Millard Jayne; Payton King; Paul Vaska
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

7.  Synthesis and evaluation of two 18F-labeled 6-iodo-2-(4'-N,N-dimethylamino)phenylimidazo[1,2-a]pyridine derivatives as prospective radioligands for beta-amyloid in Alzheimer's disease.

Authors:  Lisheng Cai; Frederick T Chin; Victor W Pike; Hiroshi Toyama; Jeih-San Liow; Sami S Zoghbi; Kendra Modell; Emmanuelle Briard; H Umesha Shetty; Kathryn Sinclair; Sean Donohue; Dnyanesh Tipre; Mei-Ping Kung; Claudio Dagostin; David A Widdowson; Michael Green; Weiyi Gao; Mary M Herman; Masanori Ichise; Robert B Innis
Journal:  J Med Chem       Date:  2004-04-22       Impact factor: 7.446

8.  [18F]fluoromethyl-[1,2-2H4]-choline: a novel radiotracer for imaging choline metabolism in tumors by positron emission tomography.

Authors:  Julius Leyton; Graham Smith; Yongjun Zhao; Meg Perumal; Quang-De Nguyen; Edward Robins; Erik Arstad; Eric O Aboagye
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

9.  Development and characterization of a promising fluorine-18 labelled radiopharmaceutical for in vivo imaging of fatty acid amide hydrolase.

Authors:  Oleg Sadovski; Justin W Hicks; Jun Parkes; Roger Raymond; José Nobrega; Sylvain Houle; Mariateresa Cipriano; Christopher J Fowler; Neil Vasdev; Alan A Wilson
Journal:  Bioorg Med Chem       Date:  2013-05-07       Impact factor: 3.641

Review 10.  PET radiotracers: crossing the blood-brain barrier and surviving metabolism.

Authors:  Victor W Pike
Journal:  Trends Pharmacol Sci       Date:  2009-07-16       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.